ClinicalTrials.Veeva

Menu

Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System (EFEL)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Cancer of the Prostate

Study type

Observational

Funder types

Other

Identifiers

NCT02879851
69HCL16_0422

Details and patient eligibility

About

The study aims at quantifying the registration error obtained in routine patients in different parts of the prostate and for operators with different experience in order to assess the average precision of the elastic MR-ultrasound fusion obtained by Koelis™ system.

Patients referred for placement of intraprostatic fiducials before radiotherapy for prostate cancer will be prospectively offered to enter the study.

The fiducials will be placed under transrectal ultrasound guidance, in the prostate apex, midgland and base, according to our routine procedure. A 3D Ultrasound acquisition of the prostate will be obtained at the end of the placement. As per our routine procedure, patients will undergo unenhanced prostate MRI to control the position of the fiducials. An elastic fusion of the MR images and the 3D ultrasound acquisitions will be retrospectively performed by operators of varying experience using the Koelis system. The fiducials (visible on MR and ultrasound images) will be used to quantify the registration error.

Enrollment

30 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Patient requiring placement of intraprostatic fiducials
  • No contra-indication for fiducials placement
  • No contra -indication to MRI
  • No contra -indication for intravenous injection of gadolinium chelates
  • Patient affiliated to the social security system
  • Patients who received oral and written information

Exclusion criteria

  • Patient deprived of liberty as a result of a judicial or administrative decision.
  • Patient under guardianship or curatorship.
  • Any event preventing or prematurely interrupting the collection of assessment criteria would result in the premature exit of the subject.

Trial contacts and locations

1

Loading...

Central trial contact

Olivier ROUVIERE, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems